A specialty pharmaceutical company focused on treatments for opioid use disorder and other substance-use and mental-health conditions, including its Suboxone and Sublocade products.
| Filer | 13FScore | This quarter | Shares | Value | % of their book |
|---|---|---|---|---|---|
| Howard Marks / Oaktree | 70 | New buy | 219,859,530 | $219,859,531 | 1.1% |
| Howard Marks / Oaktree | 70 | New buy | 6,984,102 | $212,875,428 | 1.1% |
| Bridgewater | 55 | New buy | 37,141 | $1,132,058 | 0.0% |
| Trade date | Who | Type | Amount | |
|---|---|---|---|---|
| 2026-07-01 | Trump, Donald J President | SELL | $50,001 - $100,000 | PTR |
| 2026-05-14 | Trump, Donald J President | BUY | $50,001 - $100,000 | PTR |
| 2026-05-14 | Trump, Donald J President | BUY | $15,001 - $50,000 | PTR |
| 2026-05-14 | Trump, Donald J President | BUY | $50,001 - $100,000 | PTR |
Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-07-20.